Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

Outsourcing Partnerships for CMC Development

Are strategic partnerships in clinical research a model for CMC services?
Sep 2, 2013

Are strategic partnerships in clinical research a model for CMC services?

Stability Reigns in Contract Services

The PharmTech/PharmSource annual outsourcing survey results suggest that CDMOs may be getting complacent.
Aug 1, 2013

The PharmTech/PharmSource annual outsourcing survey results suggest that CDMOs may be getting complacent.

Drug Approval Trends Don't Extend to CMOs

Approvals of new drugs are on an upward swing, but only a few CMOs are benefiting.
Jul 10, 2013

Approvals of new drugs are on an upward swing, but only a few CMOs are benefiting.

Drug Approval Trends Don't Extend to CMOs

Approvals of new drugs are on an upward swing, but only a few CMOs are benefiting.
Jun 2, 2013

Approvals of new drugs are on an upward swing, but only a few CMOs are benefiting.

Strategic Partnering for Manufacturing

Eisai and Biogen Idec pursue an innovative approach to capacity management.
May 3, 2013

Eisai and Biogen Idec pursue an innovative approach to capacity management.

Strategic Partnering for Manufacturing

Eisai and Biogen Idec pursue an innovative approach to capacity management.
Apr 2, 2013

Eisai and Biogen Idec pursue an innovative approach to capacity management.

End of the Dedicated CMO?

Is the contract-only CMO an endangered species?
Mar 6, 2013

Is the contract-only CMO an endangered species?

End of the Dedicated CMO?

Is the contract-only CMO an endangered species?
Feb 2, 2013

Is the contract-only CMO an endangered species?

The State of Outsourcing Partnerships

Preferred-provider relationships are transforming the bio/pharmaceutical industry.
Feb 1, 2013

Preferred-provider relationships are transforming the bio/pharmaceutical industry.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here